Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial

Jong-Chan Youn,1,* Eui-Soon Kim,1,* Tae Ho Park,2 Young Soo Lee,3 Soon Jun Hong,4 Jin-Yong Hwang,5 Jung-Kyu Han,6 Jung-Woo Son,7 Chan Joo Lee,8 Jung Hyun Choi,9 Sung Uk Kwon,10 Seok Yeon Kim,11 Hwan-Cheol Park,12 Seung-Hyuk Choi13 1Division of Cardiology, Department of Internal Medic...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Youn JC, Kim ES, Park TH, Lee YS, Hong SJ, Hwang JY, Han JK, Son JW, Lee CJ, Choi JH, Kwon SU, Kim SY, Park HC, Choi SH
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2026-05-01
Serija:	Drug Design, Development and Therapy
Teme:	S-amlodipine essential hypertension upfront low-dose combination therapy telmisartan
Online dostop:	https://www.dovepress.com/efficacy-and-safety-of-telmisartan-20-mgs-amlodipine-25-mg-versus-telm-peer-reviewed-fulltext-article-DDDT
Oznake:	Označite Brez oznak, prvi označite!